Epco Hasker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Epco Hasker has a total of 262 co-authors. Here are the top co-authors by number of shared publications:
- Marleen Boelaert
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
18 shared publications - Albert Picado
Affiliation Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
6 shared publications - Kristien Cloots
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
6 shared publications Paritosh Malaviya
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
6 shared publications- Nimer Ortuno-Gutierrez
Damien Foundation, 1081 Brussels, Belgium
5 shared publications - Raquel Inocêncio da Luz
Institute of Tropical Medicine Antwerp, Belgium
5 shared publications
Latest Publications
- Open Access
The road to interruption of transmission of Gambiense Human African trypanosomiasis in the Democratic Republic of the Congo, an analysis of 25 years of routine data
Introduction: Human African Trypanosomiasis (HAT) has caused hundreds of thousands of deaths in the Democratic Republic of the Congo (DRC) as recently as the 1990s. Since then annual incidence has reduced by 98% but the disease is known for its tendency of resurgence. We outlined areas at risk, HAT foci, and assessed trends in HAT infection within these foci. Methods: We applied methodology developed by WHO to outline areas at risk by period and compared surface areas from 2000-2024. Combining risk areas identified we outlined HAT foci. Within each of these foci we assessed annual numbers of HAT cases and infection rates. Results: Areas at risk have greatly reduced over the past 25 years, 67% for areas at low risk or above (≥ 1 per 100,000), 97% for areas at moderate to high risk (≥ 1 per 10,000). We outlined 15 HAT foci, all of which had been at moderate to high risk at some point in the 25-year period assessed. Three main foci account for over 80% of the total case load. Of those, the focus in the former province of Equateur rapidly declined in the early years of our analysis, while the foci in Kasai and Kwilu started to decline later. Currently 91% of all cases reported are within one of the foci outlined, most (77%) are clustered in the Kwilu focus. Discussion: Great progress has been made on the road to interruption of HAT transmission in DRC. The epidemic is now concentrated mainly in a few foci. Given these results, the advent of a new single dose oral drug, acoziborole, makes it possible to consider interruption of transmission provided current efforts are sustained. Given the tendency of resurgence it is however imperative to put in place post-elimination surveillance in all foci.
Open AccessThe road to interruption of transmission of Gambiense Human African trypanosomiasis in the Democratic Republic of the Congo, an analysis of 25 years of routine data
Introduction: Human African Trypanosomiasis (HAT) has caused hundreds of thousands of deaths in the Democratic Republic of the Congo (DRC) as recently as the 1990s. Since then annual incidence has reduced by 98% but the disease is known for its tendency of resurgence. We outlined areas at risk, HAT foci, and assessed trends in HAT infection within these foci. Methods: We applied methodology developed by WHO to outline areas at risk by period and compared surface areas from 2000-2024. Combining risk areas identified we outlined HAT foci. Within each of these foci we assessed annual numbers of HAT cases and infection rates. Results: Areas at risk have greatly reduced over the past 25 years, 67% for areas at low risk or above (≥ 1 per 100,000), 97% for areas at moderate to high risk (≥ 1 per 10,000). We outlined 15 HAT foci, all of which had been at moderate to high risk at some point in the 25-year period assessed. Three main foci account for over 80% of the total case load. Of those, the focus in the former province of Equateur rapidly declined in the early years of our analysis, while the foci in Kasai and Kwilu started to decline later. Currently 91% of all cases reported are within one of the foci outlined, most (77%) are clustered in the Kwilu focus. Discussion: Great progress has been made on the road to interruption of HAT transmission in DRC. The epidemic is now concentrated mainly in a few foci. Given these results, the advent of a new single dose oral drug, acoziborole, makes it possible to consider interruption of transmission provided current efforts are sustained. Given the tendency of resurgence it is however imperative to put in place post-elimination surveillance in all foci.
- Open Access
- 24 September 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (10) , 274
Assessing the Feasibility of an Intensified Extended Contact Survey (IECS) Compared to Passive Household Screening for Leprosy in Bangladesh
Bangladesh is among the 23 WHO priority countries for leprosy, with a new case detection rate of 21 per million population including children among new cases indicating recent transmission. We aimed to compare active versus passive case detection using geospatial tools. A cluster-randomized study was conducted across seven intervention and seven control districts. In the intervention arm, GPS coordinates of new cases were recorded, and contacts within a 75-m buffer were screened. Spatial cluster analysis using Kulldorff’s scan statistics was performed to identify hotspots. The main objective was to achieve early case detection in intervention areas, reflected in a lower proportion of new patients with grade 2 disabilities (G2Ds). A total of 347/382 (90%) index cases were enrolled in the intervention arm, compared to 380/462 (82%) in the control arm. Among household contacts, 7/1482 (5‰) new cases were found in the intervention area and 12/1565 (7.7‰) in the control area. Additionally, 18/25,720 (0.7‰) new cases were detected among neighbor contacts in the intervention arm. G2D proportions were not lower in the intervention arm (15%) than in the comparator arm (11%, p = 0.043). Comparable household contact cases were observed in both arms, with more cases emerging among neighbors in intervention districts. Eight spatial clusters were identified, including 288/844 (34%) index cases, with three significant clusters from 2022 to 2023. Screening within a 75-m buffer detected additional leprosy cases, though fewer than expected due to COVID-19 limitations. Targeting clusters for case detection and prophylaxis could strengthen transmission control efforts.
- 24 September 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (10) , 274
Open AccessAssessing the Feasibility of an Intensified Extended Contact Survey (IECS) Compared to Passive Household Screening for Leprosy in Bangladesh
Bangladesh is among the 23 WHO priority countries for leprosy, with a new case detection rate of 21 per million population including children among new cases indicating recent transmission. We aimed to compare active versus passive case detection using geospatial tools. A cluster-randomized study was conducted across seven intervention and seven control districts. In the intervention arm, GPS coordinates of new cases were recorded, and contacts within a 75-m buffer were screened. Spatial cluster analysis using Kulldorff’s scan statistics was performed to identify hotspots. The main objective was to achieve early case detection in intervention areas, reflected in a lower proportion of new patients with grade 2 disabilities (G2Ds). A total of 347/382 (90%) index cases were enrolled in the intervention arm, compared to 380/462 (82%) in the control arm. Among household contacts, 7/1482 (5‰) new cases were found in the intervention area and 12/1565 (7.7‰) in the control area. Additionally, 18/25,720 (0.7‰) new cases were detected among neighbor contacts in the intervention arm. G2D proportions were not lower in the intervention arm (15%) than in the comparator arm (11%, p = 0.043). Comparable household contact cases were observed in both arms, with more cases emerging among neighbors in intervention districts. Eight spatial clusters were identified, including 288/844 (34%) index cases, with three significant clusters from 2022 to 2023. Screening within a 75-m buffer detected additional leprosy cases, though fewer than expected due to COVID-19 limitations. Targeting clusters for case detection and prophylaxis could strengthen transmission control efforts.
- Open Access
- 1 June 2025
- Published by Lepra in Leprosy Review
- Vol. 96 (2)
Interrupting transmission of Mycobacterium leprae: synthesis of new evidence and research recommendations
On May 23–25, 2024, a multidisciplinary expert group met in Bergen, Norway, the site of the first description of Mycobacterium leprae (M. leprae) in 1873, to discuss advancements and remaining knowledge gaps in the transmission of M. leprae at the Global Partnership for Zero Leprosy Zero Transmission Symposium. Research and operational approaches to interruption of transmission were identified; the research approaches from the symposium are described here. Updates since a previous symposium at the National School of Tropical Medicine, Baylor College of Medicine in Houston (USA), in 2014 from these fields of research are presented here: epidemiology; microbiological diagnosis; immunodiagnostics; genotyping; geospatial mapping; leprosy elimination monitoring and transmission under low-endemic circumstances; leprosy post-exposure prophylaxis (PEP); modelling relevant to interruption of transmission of M. leprae; OneHealth; environmental transmission of M. leprae; social determinants; control programmes relevant to interruption of transmission of M. leprae; and organizations of persons affected. Progress and outstanding gaps since 2014 are identified, and recommendations for relevant research in these areas to achieve interruption of transmission are presented. These include research into human reservoirs, including platforms for field-friendly diagnostics; routes of entry/exit of M. leprae; the roles of animals or vectors in transmission; the role of social determinants in transmission; host-pathogen interactions; transmission networks; and enhanced epidemiological data. Fulfilment of these research recommendations and further understanding of which settings require intensified control efforts, will help to advance the aim of achieving complete interruption of transmission of M. leprae and the elimination of leprosy disease.
- 1 June 2025
- Published by Lepra in Leprosy Review
- Vol. 96 (2)
Open AccessInterrupting transmission of Mycobacterium leprae: synthesis of new evidence and research recommendations
On May 23–25, 2024, a multidisciplinary expert group met in Bergen, Norway, the site of the first description of Mycobacterium leprae (M. leprae) in 1873, to discuss advancements and remaining knowledge gaps in the transmission of M. leprae at the Global Partnership for Zero Leprosy Zero Transmission Symposium. Research and operational approaches to interruption of transmission were identified; the research approaches from the symposium are described here. Updates since a previous symposium at the National School of Tropical Medicine, Baylor College of Medicine in Houston (USA), in 2014 from these fields of research are presented here: epidemiology; microbiological diagnosis; immunodiagnostics; genotyping; geospatial mapping; leprosy elimination monitoring and transmission under low-endemic circumstances; leprosy post-exposure prophylaxis (PEP); modelling relevant to interruption of transmission of M. leprae; OneHealth; environmental transmission of M. leprae; social determinants; control programmes relevant to interruption of transmission of M. leprae; and organizations of persons affected. Progress and outstanding gaps since 2014 are identified, and recommendations for relevant research in these areas to achieve interruption of transmission are presented. These include research into human reservoirs, including platforms for field-friendly diagnostics; routes of entry/exit of M. leprae; the roles of animals or vectors in transmission; the role of social determinants in transmission; host-pathogen interactions; transmission networks; and enhanced epidemiological data. Fulfilment of these research recommendations and further understanding of which settings require intensified control efforts, will help to advance the aim of achieving complete interruption of transmission of M. leprae and the elimination of leprosy disease.
- Open Access
- 24 April 2025
- Published by Elsevier in The Lancet Global Health
- Vol. 13 (5) , e789-e790
Fexinidazole for human African trypanosomiasis: the challenge of accessibility
- 24 April 2025
- Published by Elsevier in The Lancet Global Health
- Vol. 13 (5) , e789-e790
Open AccessFexinidazole for human African trypanosomiasis: the challenge of accessibility
- Open Access
- 23 December 2024
- Published by Wiley in Tropical Medicine & International Health
- Vol. 30 (2) , 135-142
Retrospective clinical performance evaluation of the Abbott Bioline HAT 2.0, a rapid diagnostic test for human African trypanosomiasis based on recombinant antigens
Background: Rapid diagnostic tests for the serological detection of gambiense human African trypanosomiasis (gHAT) have been developed to overcome the limitations of the traditional screening method, CATT/T. b. gambiense. The Abbott Bioline human African trypanosomiasis (HAT) 2.0 rapid diagnostic test has recently been developed by Abbott using only recombinant antigens. The objective of this study was to evaluate its clinical sensitivity and specificity, in comparison with the other available rapid diagnostic tests and CATT.Methodology/Principal Findings: For this study, archived plasma samples from 150 gHAT cases and 150 endemic controls originating from Chad, Guinea, the Democratic Republic of the Congo and Uganda were analysed on the following tests: CATT/T. b. gambiense, the HAT Sero K‐SeT, SD BIOLINE HAT and Abbott Bioline HAT 2.0 rapid diagnostic tests, and the immune trypanolysis test. The sensitivity and specificity of Abbott Bioline HAT 2.0 were 96.7% and 78.4%, respectively, and the sensitivity and specificity of SD BIOLINE HAT were 99.3% and 74.1%. The sensitivity and specificity of CATT were 98.7% and 89.2%. The sensitivity and specificity of HAT Sero K‐SeT were 99.3% and 81.3%.Conclusions/Significance: The sensitivity and specificity of the Abbott Bioline HAT 2.0 are comparable to those of its predecessors HAT Sero K‐SeT and SD BIOLINE HAT. However, considering the decreasing prevalence of gHAT, a higher specificity of the tests used for screening is desirable to improve their positive predictive value.
- 23 December 2024
- Published by Wiley in Tropical Medicine & International Health
- Vol. 30 (2) , 135-142
Open AccessRetrospective clinical performance evaluation of the Abbott Bioline HAT 2.0, a rapid diagnostic test for human African trypanosomiasis based on recombinant antigens
Background: Rapid diagnostic tests for the serological detection of gambiense human African trypanosomiasis (gHAT) have been developed to overcome the limitations of the traditional screening method, CATT/T. b. gambiense. The Abbott Bioline human African trypanosomiasis (HAT) 2.0 rapid diagnostic test has recently been developed by Abbott using only recombinant antigens. The objective of this study was to evaluate its clinical sensitivity and specificity, in comparison with the other available rapid diagnostic tests and CATT.Methodology/Principal Findings: For this study, archived plasma samples from 150 gHAT cases and 150 endemic controls originating from Chad, Guinea, the Democratic Republic of the Congo and Uganda were analysed on the following tests: CATT/T. b. gambiense, the HAT Sero K‐SeT, SD BIOLINE HAT and Abbott Bioline HAT 2.0 rapid diagnostic tests, and the immune trypanolysis test. The sensitivity and specificity of Abbott Bioline HAT 2.0 were 96.7% and 78.4%, respectively, and the sensitivity and specificity of SD BIOLINE HAT were 99.3% and 74.1%. The sensitivity and specificity of CATT were 98.7% and 89.2%. The sensitivity and specificity of HAT Sero K‐SeT were 99.3% and 81.3%.Conclusions/Significance: The sensitivity and specificity of the Abbott Bioline HAT 2.0 are comparable to those of its predecessors HAT Sero K‐SeT and SD BIOLINE HAT. However, considering the decreasing prevalence of gHAT, a higher specificity of the tests used for screening is desirable to improve their positive predictive value.
- Open Access
- 25 June 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107153
Monitoring of Leishmania transmission in the postelimination phase: The potential of serological surveys
- 25 June 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107153
Open AccessMonitoring of Leishmania transmission in the postelimination phase: The potential of serological surveys
- Open Access
- 16 May 2024
- Published by Elsevier in The Lancet Global Health
- Vol. 12 (6) , e1017-e1026
Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial
- 16 May 2024
- Published by Elsevier in The Lancet Global Health
- Vol. 12 (6) , e1017-e1026
Open AccessPost-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial
- Open Access
Source tracing of Leishmania donovani in emerging foci of visceral leishmaniasis in West Nepal
We sequenced Leishmania donovani genomes in blood samples collected in emerging foci of Visceral Leishmaniasis, in West Nepal. We detected lineages which are very different from pre-elimination main parasite population: a new lineage and a rare one previously reported once in East Nepal. We highlight the need for genomic surveillance.
Open AccessSource tracing of Leishmania donovani in emerging foci of visceral leishmaniasis in West Nepal
We sequenced Leishmania donovani genomes in blood samples collected in emerging foci of Visceral Leishmaniasis, in West Nepal. We detected lineages which are very different from pre-elimination main parasite population: a new lineage and a rare one previously reported once in East Nepal. We highlight the need for genomic surveillance.
- Open Access
- 14 June 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (6) , e0001325
Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo
Gambiense Human African Trypanosomiasis (g-HAT) is a neglected tropical disease caused by trypanosomes transmitted by tsetse flies. In 2017, a pilot community-based project was launched in three villages in DRC with the overall goal of empowering community members to control tsetse using Tiny Targets which attract and kill tsetse. In this paper, we assess the community participation process in these three pilot villages over >4 years and evaluate to what extent this resulted in the empowerment of communities. We conducted a qualitative study using a participatory research approach. Together with community members of the three pilot villages from the endemic Kwilu province, we evaluated changes in project participation, community empowerment and perception of future participation at three different time points (September 2017, September 2018 and November 2021) over a 4-year period using participatory workshops and focus group discussions (FGD). We used a thematic content approach to analyse both workshop notes and FGD transcripts. The community identified five indicators to evaluate participation: (1) Leadership & Ownership, (2) Organisation & Planning, (3) Willingness, (4) Autonomy and (5) Community Involvement. The participation experience described by community members was characterised by a rapid growth of empowerment in the first year and sustained high levels thereafter. Community participants were willing to engage in potential future projects and continue to be supported by their Tiny Target project partner. However, they identified an imbalance in the power relationship within the committee and with the Tiny Target partners that limit the extent of empowerment attained. The intervention had broader benefits of community empowerment but this was limited by perceptions of being part of wider “top down” programme and by stakeholders attitude toward community participation. If empowerment is to be an important objective of projects and programmes then the needs identified by communities must be recognised and attitude of sharing power encouraged.
- 14 June 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (6) , e0001325
Open AccessCommunity empowerment through participation in a tsetse control project in the Democratic Republic of Congo
Gambiense Human African Trypanosomiasis (g-HAT) is a neglected tropical disease caused by trypanosomes transmitted by tsetse flies. In 2017, a pilot community-based project was launched in three villages in DRC with the overall goal of empowering community members to control tsetse using Tiny Targets which attract and kill tsetse. In this paper, we assess the community participation process in these three pilot villages over >4 years and evaluate to what extent this resulted in the empowerment of communities. We conducted a qualitative study using a participatory research approach. Together with community members of the three pilot villages from the endemic Kwilu province, we evaluated changes in project participation, community empowerment and perception of future participation at three different time points (September 2017, September 2018 and November 2021) over a 4-year period using participatory workshops and focus group discussions (FGD). We used a thematic content approach to analyse both workshop notes and FGD transcripts. The community identified five indicators to evaluate participation: (1) Leadership & Ownership, (2) Organisation & Planning, (3) Willingness, (4) Autonomy and (5) Community Involvement. The participation experience described by community members was characterised by a rapid growth of empowerment in the first year and sustained high levels thereafter. Community participants were willing to engage in potential future projects and continue to be supported by their Tiny Target project partner. However, they identified an imbalance in the power relationship within the committee and with the Tiny Target partners that limit the extent of empowerment attained. The intervention had broader benefits of community empowerment but this was limited by perceptions of being part of wider “top down” programme and by stakeholders attitude toward community participation. If empowerment is to be an important objective of projects and programmes then the needs identified by communities must be recognised and attitude of sharing power encouraged.